Advances in the Targeted Drug Delivery System for Renal Fibrosis
Yan-Yan Zheng, Ji-Fu Hao, Jin-Ye Liu, Shu-Yu Wang, Xiao-Dong Mu, Hu-Lin Jiang, Yu-Jing He · 2026
Read Advances in the Targeted Drug Delivery System for Renal Fibrosis by Yan-Yan Zheng, Ji-Fu Hao, Jin-Ye Liu, Shu-Yu Wang, Xiao-Dong Mu, Hu-Lin Jiang, Yu-Jing He (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13290427.txt.
Description
Getting drugs to exactly the kidney cells that drive scarring is the goal reviewed by Yan-Yan Zheng and colleagues in 2026. Renal fibrosis is the shared end point of nearly all chronic kidney diseases and the main road to kidney failure, yet most candidate drugs fail before clinical use.
The review blames complex signaling networks, the kidney's layered structure, and barriers that keep medicines from reaching lesions. It then surveys delivery systems that carry several drugs at once on nanoplatforms decorated with targeting ligands, aiming at effector cells such as myofibroblasts and tubular epithelial cells. Zheng and colleagues weigh the remaining challenges and sketch where targeted delivery for reversing fibrosis should head next.
Catalog record
| CREATOR | Yan-Yan Zheng, Ji-Fu Hao, Jin-Ye Liu, Shu-Yu Wang, Xiao-Dong Mu, Hu-Lin Jiang, Yu-Jing He |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 76614 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |